Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
10 eventsNational Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
University of Tennessee Graduate School of Medicine — PHASE2
Assistance Publique - Hôpitaux de Paris
Huazhong University of Science and Technology — NA
Assiut University
Children's Hospital Medical Center, Cincinnati — PHASE2
University Hospital Heidelberg
Mayo Clinic — NA
Hivid: FDA approved
Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration.
Retrovir: FDA approved
Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
2 availableHivid
Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration…
Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration.
Retrovir
Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 hel…
Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesTriamcinolone acetonide, TRIAMCINOLONE ACETONIDE
Unknown
Inflammatory conditions
Travel Grants
No travel grants are currently matched to AA amyloidosis.
Community
No community posts yet. Be the first to share your experience with AA amyloidosis.
Start the conversation →Latest news about AA amyloidosis
Disease timeline:
New recruiting trial: Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections
A new clinical trial is recruiting patients for AA amyloidosis
New recruiting trial: Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
A new clinical trial is recruiting patients for AA amyloidosis
New recruiting trial: Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
A new clinical trial is recruiting patients for AA amyloidosis
New recruiting trial: Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
A new clinical trial is recruiting patients for AA amyloidosis
New recruiting trial: DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
A new clinical trial is recruiting patients for AA amyloidosis
New recruiting trial: Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
A new clinical trial is recruiting patients for AA amyloidosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about AA amyloidosis
Are there clinical trials for AA amyloidosis?
Yes — 4 recruiting clinical trials are currently listed for AA amyloidosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat AA amyloidosis?
25 specialists and care centers treating AA amyloidosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for AA amyloidosis?
2 patient support programs are currently tracked on UniteRare for AA amyloidosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.